Prescription window for females of reproductive potential is 7 days beginning with the date of the pregnancy test specimen collection.
Prescription window for females of non-reproductive potential and males is 30 days beginning with date of the office visit.
About Prescriber Information
The goals of the iPLEDGE Program are to prevent fetal exposure to isotretinoin
and to inform prescribers, pharmacists, and patients about isotretinoin's serious risks
and safe-use conditions. The resources below present the program requirements and help
you prepare and plan treatments with patients during the course of isotretinoin therapy.
View Information Online
You can click on each link to view the material online. Upon clicking on a
link, each file will be launched in a new browser window. To view these PDF
files, you will need
Manufacturer's Toll-free Numbers
For more information about the specific brands of isotretinoin, call the
individual manufacturers at these numbers.
|Product Name||Company||Phone Number|
|Amnesteem®||Mylan Pharmaceuticals Inc.||1-800-796-9526|
|Claravis®||Teva Pharmaceuticals USA.||1-800-227-7522|
|Sotret®||Ranbaxy Laboratories, Inc.||1-800-406-7984|
|Absorica™||Ranbaxy Laboratories, Inc.||1-800-406-7984|
|Zenatane™||Dr. Reddy's Laboratories, Ltd.||1-888-375-3784|